Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Transplant Recipients With Anti-HLA Antibodies”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableEnded earlyNCT02115503
What this trial is testing

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients

Who this might be right for
Renal Transplant Recipients With Anti-HLA Antibodies
Databean 52
Testing effectiveness (Phase 2)Study completedNCT02738918
What this trial is testing

Belatacept (Nulojix) in Renal Transplant Recipient With Mild Immunologic Risk Factor: a Pilot Prospective Study.

Who this might be right for
Renal TransplantAcute Antibody Mediated RejectionMild Immunologic Risk Factor
Assistance Publique - Hôpitaux de Paris 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04827979
What this trial is testing

Daratumumab and Belatacept for Desensitization

Who this might be right for
Highly Sensitized Prospective Kidney Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 19
Post-approval studies (Phase 4)UnknownNCT02208791
What this trial is testing

Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

Who this might be right for
Kidney Transplantation
University of Sao Paulo General Hospital 45